Abstract

Immunogenic cell death (ICD) and tumour-infiltrating T lymphocytes are severely weakened by elevated reactive oxygen species (ROS) in the tumour microenvironment. It is therefore of critical importance to modulate the level of extracellular ROS for the reversal of immunosuppressive environment. Here, we present a tumour extracellular matrix (ECM) targeting ROS nanoscavenger masked by pH sensitive covalently crosslinked polyethylene glycol. The nanoscavenger anchors on the ECM to sweep away the ROS from tumour microenvironment to relieve the immunosuppressive ICD elicited by specific chemotherapy and prolong the survival of T cells for personalized cancer immunotherapy. In a breast cancer model, elimination of the ROS in tumour microenvironment elicited antitumour immunity and increased infiltration of T lymphocytes, resulting in highly potent antitumour effect. The study highlights a strategy to enhance the efficacy of cancer immunotherapy by scavenging extracellular ROS using advanced nanomaterials.

Highlights

  • Immunogenic cell death (ICD) and tumour-infiltrating T lymphocytes are severely weakened by elevated reactive oxygen species (ROS) in the tumour microenvironment

  • Recent studies revealed that immunogenic cell death (ICD) elicited by specific chemotherapy or radiotherapy makes the dead cell corpses ‘visible’ to dendritic cells (DCs) that present antigens to T cells with specific antitumour immune responses, which control residual tumour cells[6,7,8,9]

  • The antitumour immunity triggered by ICD is limited, which is mainly due to the dysfunctional T cells in the tumour microenvironment (TME)

Read more

Summary

Introduction

Immunogenic cell death (ICD) and tumour-infiltrating T lymphocytes are severely weakened by elevated reactive oxygen species (ROS) in the tumour microenvironment. The significantly reduced expression of HMGB1 in intracellular 4T1 cells treated with free OLE and PEG-TECM-NS/OLE pretreated at pH 6.8 with 100 μM The frequency of CD80+CD86+ mature BMDCs after co-culture with 4T1 tumour cells pretreated with free OLE was significantly higher that of the control group, indicating that ICD from dying

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.